Effect of probiotics on intestinal inflammation in CF patients whit age morthan 4 years

Not Applicable

• Conditions: cystic fibrosis.; cystic fibrosis with intestinal manifestation; E 84.1

• Registration Number: IRCT201201258778N3
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

inclusion criteria; cf patient ; age morethan 4years ; pancrease insuficient ; un use NSAID for 2 weaks ago

exclusion criteria; age before 4 years ; pancrease sufficient ; use NSAID during 2 weaks ago

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fecal calprotectin. Timepoint: befor of the study and one mounth later. Method of measurement: measurement of fecal calprotectin.